Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
Start Date
3/10/2021
Completion Date
2/1/2027
Summary
This is a randomized controlled study of parents of children to be discharged from the neonatal intensive care unit at Bellevue and Elmhurst hospitals. A total of 425 subjects will be recruited across two sites over preparatory phases and two primary study phases.
Detailed Description
Our overarching goal is to promote safe medication use/adherence for high-risk infants, by leveraging health literacy approaches and mobile technology to reinforce provider counseling and support parent medication management after discharge from the NICU. We will adapt/integrate evidence-based strategies studied in less complex populations, for this vulnerable group. The HELPix (Health Education and Literacy for Parents) pictogram-based intervention, developed by our team, incorporates these strategies, with sizeable improvements found in medication knowledge, dosing errors, and adherence in outpatient general pediatric settings, but to date, HELPix has not been studied in NICU settings
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
HELPix
HELPix+Tech
Conditions
Locations
NYU Langone Health
New York, New York 10016
United States